Fast-fail trial shows new approach to identifying brain targets for clinical treatments
A first-of-its-kind trial has demonstrated that a receptor involved in the brain's reward system may be a viable target for treating anhedonia (or lack of pleasure), a key symptom of several mood and anxiety disorders. This ...
Mar 30, 2020
0
160